Matsuoka Corporation (3611.T)
JPY 1975.0
(-0.5%)
JPY 1975.0
(-0.5%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 5.4 Billion | -506 Million | 821 Million | 6.64 Billion | 2.28 Billion | 4.87 Billion |
| Net Income | 2.45 Billion | 2.9 Billion | 1.13 Billion | 4.06 Billion | 2.19 Billion | 5.21 Billion |
| Depreciation & Amortization | 2.12 Billion | 1.84 Billion | 1.28 Billion | 1.28 Billion | 1.39 Billion | 1.09 Billion |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 84 Million | -4.44 Billion | 121 Million | 1.61 Billion | 385 Million | 1.84 Billion |
| Other non-cash items | 5.27 Billion | -809 Million | -1.72 Billion | -316 Million | -1.69 Billion | -3.27 Billion |
| Investing Cash Flow | -2.57 Billion | -6.19 Billion | -2.81 Billion | -341 Million | -1.49 Billion | -3.31 Billion |
| Investments in PPE | -2.51 Billion | -6.31 Billion | -2.56 Billion | -2.34 Billion | -1.42 Billion | -5.05 Billion |
| Acquisitions | 84 Million | -181 Million | -42 Million | 49 Million | -463 Million | -704 Million |
| Investment purchases | -424 Million | -557 Million | -357 Million | -12 Million | -12 Million | -81 Million |
| Sales/Maturities of investments | 388 Million | 395 Million | -46 Million | 77 Million | 43 Million | 106 Million |
| Other Investing Activities | -108 Million | 459 Million | 202 Million | 1.89 Billion | 362 Million | 2.41 Billion |
| Financing Cash Flow | -753 Million | 4.9 Billion | 3.14 Billion | -2.34 Billion | -144 Million | -1.38 Billion |
| Debt repayment | -246 Million | -1.07 Billion | -1.18 Billion | -2.13 Billion | -153 Million | -468 Million |
| Dividends payments | -399 Million | -392 Million | -391 Million | -401 Million | -499 Million | -397 Million |
| Common Stock Repurchased | - | 6.18 Billion | 4.7 Billion | -743 Million | 481 Million | -1.75 Billion |
| Common Stock Issuance | - | 196 Million | 17 Million | 22 Million | 29 Million | 53 Million |
| Other Financing Activities | 3 Million | -2 Million | -3 Million | 909 Million | -2 Million | 1.17 Billion |
| Accounts receivables | -1.41 Billion | -1.18 Billion | 563 Million | 2.66 Billion | -645 Million | 276 Million |
| Accounts payables | 1.03 Billion | -2.03 Billion | 460 Million | -1.76 Billion | -131 Million | 662 Million |
| Inventory | 105 Million | -1.2 Billion | -960 Million | 589 Million | 306 Million | 169 Million |
| Other working capital | 360 Million | -22 Million | 58 Million | 135 Million | 855 Million | 734 Million |
| Cash at beginning of period | 14.48 Billion | 15.2 Billion | 12.85 Billion | 9.01 Billion | 8.49 Billion | 8.48 Billion |
| Cash at end of period | 17.17 Billion | 14.48 Billion | 15.2 Billion | 12.85 Billion | 9.01 Billion | 8.49 Billion |
| Capital Expenditure | -2.51 Billion | -6.31 Billion | -2.56 Billion | -2.34 Billion | -1.42 Billion | -5.05 Billion |
| Effect of forex changes on cash | 621 Million | 1.06 Billion | 1.19 Billion | -122 Million | -121 Million | -166 Million |
| Net cash flow / Change in cash | 2.69 Billion | -725 Million | 2.35 Billion | 3.83 Billion | 523 Million | 4 Million |
| Free Cash Flow | 2.89 Billion | -6.81 Billion | -1.74 Billion | 4.3 Billion | 859 Million | -182 Million |
| Breakdown | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 780 Million | 2.45 Billion | 541 Million | 632 Million | 677 Million | 607 Million |
| Depreciation & Amortization | - | 2.12 Billion | - | 295 Million | 560 Million | 399 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | 84 Million | - | - | - | - |
| Other non-cash items | -780 Million | 5.27 Billion | -541 Million | -632 Million | -677 Million | -607 Million |
| Investing Cash Flow | - | -2.57 Billion | - | - | - | - |
| Investments in PPE | - | -2.51 Billion | - | - | - | - |
| Acquisitions | - | 84 Million | - | - | - | - |
| Investment purchases | - | -424 Million | - | - | - | - |
| Sales/Maturities of investments | - | 388 Million | - | - | - | - |
| Other Investing Activities | - | -108 Million | - | - | - | - |
| Financing Cash Flow | - | -753 Million | - | - | - | - |
| Debt repayment | - | -246 Million | - | - | - | - |
| Dividends payments | - | -399 Million | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | 3 Million | - | - | - | - |
| Accounts receivables | - | -1.41 Billion | - | - | - | - |
| Accounts payables | - | 1.03 Billion | - | - | - | - |
| Inventory | - | 105 Million | - | - | - | - |
| Other working capital | - | 360 Million | - | - | - | - |
| Cash at beginning of period | - | 14.48 Billion | - | 15 Billion | 16.33 Billion | 14.48 Billion |
| Cash at end of period | - | 17.17 Billion | - | 21.09 Billion | 15 Billion | 16.33 Billion |
| Capital Expenditure | - | -2.51 Billion | - | - | - | - |
| Effect of forex changes on cash | - | 621 Million | - | - | - | - |
| Net cash flow / Change in cash | - | 2.69 Billion | - | 6.08 Billion | -1.32 Billion | 1.85 Billion |
| Free Cash Flow | - | 2.89 Billion | - | 590 Million | 1.12 Billion | 798 Million |
PGM
AAREYDRUGS
SUGALDAM
6724
JUBLPHARMA
EKH